(Q32872171)

11 July 2017

title

miR-106a promotes cardiac hypertrophy by targeting mitofusin 2. (English)

1 reference

11 July 2017

Xiaoxiang Guan

1

1 reference

11 July 2017

Lu Wang

2

1 reference

11 July 2017

Zhenhong Liu

3

1 reference

11 July 2017

Xiaofei Guo

4

1 reference

11 July 2017

Yuan Jiang

5

1 reference

11 July 2017

Ying Lu

6

1 reference

11 July 2017

Yanli Peng

7

1 reference

11 July 2017

Tianhua Liu

8

1 reference

11 July 2017

Baofeng Yang

9

1 reference

11 July 2017

Hongli Shan

10

1 reference

11 July 2017

Yong Zhang

11

1 reference

11 July 2017

Chaoqian Xu

12

1 reference

11 July 2017

publication date

23 August 2016

1 reference

Journal of Molecular and Cellular Cardiology

11 July 2017

published in

1 reference

11 July 2017

volume

99

1 reference

11 July 2017

page(s)

207-217

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

11 July 2017

1 reference

ECM remodeling in hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Regulation of cardiac hypertrophy by intracellular signalling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

MicroRNAs: genomics, biogenesis, mechanism, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

MicroRNA-328 as a regulator of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

MiR-17-92 cluster is a novel regulatory gene of cardiac ischemic/reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Loss of mitofusin 2 promotes endoplasmic reticulum stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Dysregulation of HSG triggers vascular proliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

IHG-1 increases mitochondrial fusion and bioenergetic function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

A Mitofusin-2-dependent inactivating cleavage of Opa1 links changes in mitochondria cristae and ER contacts in the postprandial liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitofusin 2-containing mitochondrial-reticular microdomains direct rapid cardiomyocyte bioenergetic responses via interorganelle Ca(2+) crosstalk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Central role of mitofusin 2 in autophagosome-lysosome fusion in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Downregulation of miR-151-5p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Downregulation of miR-133 via MAPK/ERK signaling pathway involved in nicotine-induced cardiomyocyte apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitochondrial respiration and microRNA expression in right and left atrium of patients with atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Detection of miR-106a in gastric carcinoma and its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Control of stress-dependent cardiac growth and gene expression by a microRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

MicroRNA-133 controls cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitochondrial dynamics in cardiovascular health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitochondria: in sickness and in health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

Dysregulation of Mfn2 and Drp-1 proteins in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.08.016

10.1016/J.YJMCC.2016.08.016

7 January 2021

Identifiers

DOI

1 reference

11 July 2017

1 reference